Fmr LLC Tango Therapeutics, Inc. Transaction History
Fmr LLC
- $1.52 Trillion
- Q2 2024
A detailed history of Fmr LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 9,409,078 shares of TNGX stock, worth $27.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,409,078
Previous 9,491,655
0.87%
Holding current value
$27.8 Million
Previous $75.4 Million
7.12%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding TNGX
# of Institutions
121Shares Held
86.8MCall Options Held
2.6KPut Options Held
1K-
Trv Gp Iv, LLC Boston, MA16.9MShares$49.7 Million80.09% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA13.3MShares$39.3 Million4.04% of portfolio
-
Boxer Capital, LLC San Diego, CA8.2MShares$24.2 Million3.91% of portfolio
-
Nextech Invest Ag5.53MShares$16.3 Million8.96% of portfolio
-
Southpoint Capital Advisors LP New York, NY5.28MShares$15.6 Million1.32% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $260M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...